Flk-1/Flt-4 Polyclonal Antibody

Alias:KDR;FLK1;VEGFR2;Vascular endothelial growth factor receptor 2;VEGFR-2;Fetal liver kinase 1;FLK-1;Kinase insert domain receptor;KDR;Protein-tyrosine kinase receptor flk-1;CD antigen CD309;FLT4;VEGFR3;Vascular endothelial growth

CatalogNo:HJRLT1726

Specifications

50μL;100μL

Delivery date

Spot

Target

VEGFR2/VEGFR3

Reactivity

Human,Mouse,Rat

Application - After Update

IHC,IF,ELISA

MW(Calculated)

152kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:40000;Not yet tested in other applications.

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human VEGFR2. AA range:1020-1069

Specificity

Flk-1/Flt-4 Polyclonal Antibody detects endogenous levels of Flk-1/Flt-4 protein.

Gene name

KDR/FLT4

Protein name

Vascular endothelial growth factor receptor 2/3

Organism-1

Human